References
- Sun HY, Singh N. Opportunistic infection-associated immune reconstitution syndrome in transplant recipients. Clin Infect Dis. 2011;53(2):168–176. doi:10.1093/cid/cir276
- Lanzafame M, Vento S. Tuberculosis-immune reconstitution inflammatory syndrome. J Clin Tuberc Other Mycobact Dis. 2016;3:6–9. doi:10.1016/j.jctube.2016.03.002
- Phillips P, Bonner S, Gataric N, et al. Nontuberculous mycobacterial immune reconstitution syndrome in HIV-Infected patients: spectrum of disease and Long-Term Follow-Up. Clin Infect Dis. 2005;41; (10):1483–1497. doi:10.1086/497269
- de Araujo Eyer-Silva W, Rodrigues de Almeida M, Martins CJ, et al. Antiretroviral therapy-induced paradoxical worsening of previously healed Mycobacterium haemophilum cutaneous lesions in advanced HIV infection. Rev Inst Med Trop Sao Paulo. 2019;61:e71.
- Shah MK, Sebti A, Kiehn TE, et al. Mycobacterium haemophilum in immunocompromised patients. Clin Infect Dis. 2001;33;(3):330–337. doi:10.1086/321894
- Jacobs SE, Zhong E, Hartono C, et al. The brief case: dissemminated Mycobacterium haemophilum infection in a kidney transplant recipient. J Clin Microbiol. 2018;56(1):e00561-17. doi:10.1128/JCM.00562-17
- Brix SR, Iking-Konert C, Stahl RA, et al. DissemminatedMycobacterium haemophilum infection in a renal transplant patient. BMJ Case Rep. 2016;2016:bcr2016216042. doi:10.1136/bcr-2016-216042
- Cross GB, Le Q, Webb B, et al. Mycobacterium haemophilum bone and joint infection in HIV/AIDS: case report and literature review. Int J STD AIDS. 2015;26(13):974–981. Novdoi:10.1177/0956462414565403
- Baluch A, Pasikhova Y, Snyder M. Successful management of Mycobacterium haemophilum lower extremity cutaneous infection in a matched-unrelated donor stem cell transplant recipient. Transpl Infect Dis. 2017;19(1):e12627. doi:10.1111/tid.12627
- Meintjes G, Stek C, Blumenthal L, et al. Prednisone for the prevention of paradoxical Tuberculosis-Associated IRIS. N Engl J Med. 2018;379(20):1915–1925. doi:10.1056/NEJMoa1800762